The loss of a true Giant in breast cancer research and discovery. An extraordinary example for the generations #breast cancer #mbc mdanderson.org/newsroom/md-an…

America's Best Hospitals: the 2024-2025 Honor Roll and Overview health.usnews.com/health-care/be… Congratulations to my colleagues for the recognition of excellence! @nyp Weill Cornell Medicine Herbert Irving Comprehensive Cancer Center Weill Cornell Medicine Meyer Cancer Center

Congratulations to a junior rising star! Weill Cornell Medicine Meyer Cancer Center Weill Cornell Medicine WCM Englander Institute for Precision Medicine

Excellent example of combination of clinical and molecular data to predict activity of targeted single agent in HR+ MBC. International Society of Liquid Biopsy WCM Englander Institute for Precision Medicine #MBC

Moving ctDNA to for early detection of solid tumors is becoming a reality and will change the screening for populations and high risk individuals International Society of Liquid Biopsy WCM Englander Institute for Precision Medicine reuters.com/business/healt…

The journey that changed cancer diagnostics: vision, research, clinical application. WCM Englander Institute for Precision Medicine Weill Cornell Medicine Meyer Cancer Center International Society of Liquid Biopsy AACR Weill Cornell Medicine Meyer Cancer Center NewYork-Presbyterian ASCO

The 2024 Kona Breast Cancer Summit started yesterday. I must say this is the best networking event, a place to seek new ideas and establish collaboration for breast cancer oncologists and researchers in the USA. #davabreast

Starting Now: Inflammatory Breast Cancer Moderated by: Massimo Cristofanilli, MD, FACP Weill Cornell Medicine #DAVABreast

One Week Left! 🕒 Time is running out to submit your abstract for #ISLB24! Don’t miss the opportunity to showcase your research and contribute to the future of #liquidbiopsy. The abstract submission deadline is September 3, 2024. Submit now and make your mark at

Tuning Immune‐Cold Tumor by Suppressing USP10/B7‐H4 Proteolytic Axis Reinvigorates Therapeutic Efficacy of ADCs - Zeng - Advanced Science - Wiley Online Library onlinelibrary.wiley.com/doi/10.1002/ad…

Last Call! Abstract submission for #ISLB24 ends tomorrow, September 3 (23:59 CEST). ⏳ Don’t miss your opportunity to contribute to the future of #liquidbiopsy. Submit your research now at 2024.islb.info/b5dv and join leading experts in Denver, Colorado, USA, from November

tethis-lab.com/news/tethis-s-… WCM Englander Institute for Precision Medicine Weill Cornell Medicine Cornell University

Circulating Tumor DNA and Survival in Metastatic Breast Cancer jamanetwork.com/journals/jaman… WCM Englander Institute for Precision Medicine International Society of Liquid Biopsy Weill Cornell Medicine Meyer Cancer Center

Guardant Health, Inc. - Guardant Health and Policlinico Gemelli Announce Partnership to Establish A Dedicated In-House Liquid Biopsy Testing Service in Italy. ⁦International Society of Liquid Biopsy⁩ investors.guardanthealth.com/press-releases…

KN-522 trial shows promising results in TNBC (Stage II-III)! Pembrolizumab + Chemo improves EFS and OS. A new SoC for #TNBC. 💪 @oncoalert ESMO - Eur. Oncology #cancer #oncology #ESMO24 Toni Choueiri, MD Evandro de Azambuja, MD, PhD Andres Cervantes FabriceAndre

Excellent paper using CTCs and ctDNA in EBC. International Society of Liquid Biopsy Cristofanilli CTC Laboratory WCM Englander Institute for Precision Medicine Carolina Reduzzi Eleonora Nicolò Lorenzo Gerratana

Exploring the additional prognostic value of CTCs count in predicting site -specific metastatic behavior. International Society of Liquid Biopsy #mbc WCM Englander Institute for Precision Medicine Cristofanilli CTC Laboratory

Increasing and persistent benefit of the combination nivolumab-Ipilimumab suggesting achieved cure in advanced melanoma. Weill Cornell Medicine Meyer Cancer Center Weill Department of Medicine

Liquid biopsy provides new insights into the clinical and biological behavior of IBC in real-time in the unique environment of the IBC patient. Cristofanilli CTC Laboratory International Society of Liquid Biopsy IBCIC Wendy Woodward MDPhD

🧬 New review explores the transformative potential of liquid biopsy in triple-negative breast cancer (#TNBC)! 🚀 This technology could revolutionize treatment by identifying biomarkers for early relapse, monitoring disease progression, and tailoring therapies. 📊 Stay tuned for